Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 10:22AM
|
Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 27, 2021 06:57PM
|
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
1
|
Resverlogix Corp.
|
Apr 27, 2021 03:32PM
|
Re: How many other "Alex Kopacz's" are out there...as we wait our turn on the tarmac?
|
5
|
Resverlogix Corp.
|
Apr 27, 2021 11:55AM
|
Re: Study readouts this week or next?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 27, 2021 09:37AM
|
Re: Study readouts this week or next?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 27, 2021 08:54AM
|
Re: Where is the trial?
|
2
|
Resverlogix Corp.
|
Apr 24, 2021 06:27PM
|
Re: Where is the trial?
|
2
|
Resverlogix Corp.
|
Apr 24, 2021 06:52AM
|
Short Interest
|
3
|
Resverlogix Corp.
|
Apr 23, 2021 09:31AM
|
Re: Still not finding on ClinicalTrials gov
|
1
|
Resverlogix Corp.
|
Apr 23, 2021 05:32AM
|
Re: Still not finding on ClinicalTrials gov
|
1
|
Resverlogix Corp.
|
Apr 22, 2021 08:53PM
|
Re: Still not finding on ClinicalTrials gov
|
1
|
Resverlogix Corp.
|
Apr 22, 2021 07:50PM
|
Re: COVID 19 - Standard of Care
|
5
|
Resverlogix Corp.
|
Apr 22, 2021 06:58PM
|
Re: Still not finding on ClinicalTrials gov
|
2
|
Resverlogix Corp.
|
Apr 22, 2021 01:24PM
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
3
|
Zenith Epigenetics
|
Apr 22, 2021 11:11AM
|
Re: Still not finding on ClinicalTrials gov
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 05:15AM
|
COVID 19 - Standard of Care
|
1
|
Resverlogix Corp.
|
Apr 21, 2021 02:07PM
|
Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir
|
4
|
Resverlogix Corp.
|
Apr 19, 2021 09:08AM
|
Re: Posted on other board by jkj from Google alert / Old or new news?
|
1
|
Resverlogix Corp.
|
Apr 19, 2021 07:53AM
|
Re: Another Exempt Distribution - 2021-04-15
|
2
|
Resverlogix Corp.
|
Apr 18, 2021 08:26AM
|